Fusarium fungaemia in immunocompromised patients.
Fusarium spp. cause infections only rarely in immunologically competent hosts, but disseminated infection may occur in severely immunocompromised patients. Symptoms of disseminated infection are persistent fever, despite broad-spectrum antibacterial and antifungal treatment, associated with skin lesions, most commonly on the extremities, in 60-80% of patients. A mortality rate of 50-75% has been reported for patients with disseminated fusariosis. Despite treatment failures, amphotericin B remains the preferred drug, in part because of lack of alternatives. Voriconazole is a promising new agent, but more clinical experience is required.
Jensen
T G
TG
Department of Clinical Microbiology, Odense University Hospital, Odense, Denmark. t.g.jensen@ouh.fyns-amt.dk
Gahrn-Hansen
B
B
Arendrup
M
M
Bruun
B
B
D000368:Aged; D003718:Denmark; D005260:Female; D016469:Fungemia / Q000175:diagnosis* / Q000382:microbiology; D005670:Fusarium / Q000302:isolation & purification*; D006402:Hematologic Diseases / Q000150:complications*; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000175:diagnosis / Q000382:microbiology